no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers
|
Choi, Yoo Jin |
|
2013 |
17 |
2 |
p. 247-254 |
article |
2 |
A case of single lymph node metastasis near the common hepatic artery following a curative endoscopic resection for gastric mucosal cancer
|
Kim, Dong Jin |
|
2013 |
17 |
2 |
p. 387-391 |
article |
3 |
A nomogram for predicting individual survival of patients with gastric cancer who underwent radical surgery with extended lymph node dissection
|
Song, Kyo Young |
|
2013 |
17 |
2 |
p. 287-293 |
article |
4 |
A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer
|
Moriwaki, Toshikazu |
|
2013 |
17 |
2 |
p. 354-361 |
article |
5 |
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort
|
Pernot, Simon |
|
2013 |
17 |
2 |
p. 341-347 |
article |
6 |
Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer?
|
Choi, Yoon Young |
|
2013 |
17 |
2 |
p. 310-315 |
article |
7 |
Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy
|
Takiguchi, Shuji |
|
2013 |
17 |
2 |
p. 200-205 |
article |
8 |
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer
|
Shitara, Kohei |
|
2013 |
17 |
2 |
p. 362-370 |
article |
9 |
Endoscopic submucosal dissection for early gastric cancer in anastomosis site after distal gastrectomy
|
Tanaka, Shinwa |
|
2013 |
17 |
2 |
p. 371-376 |
article |
10 |
Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection
|
Ghoshal, Ujjala |
|
2013 |
17 |
2 |
p. 226-234 |
article |
11 |
Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells
|
Perrais, Michaƫl |
|
2013 |
17 |
2 |
p. 235-246 |
article |
12 |
High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302
|
Miyashiro, Isao |
|
2013 |
17 |
2 |
p. 316-323 |
article |
13 |
Laparoscopic wedge resection of the stomach for gastrointestinal stromal tumor (GIST): non-touch lesion lifting method
|
Kiyozaki, Hirokazu |
|
2013 |
17 |
2 |
p. 337-340 |
article |
14 |
Limited subtotal gastrectomy for early remnant gastric cancer
|
Hosokawa, Yuichi |
|
2013 |
17 |
2 |
p. 332-336 |
article |
15 |
Mortalin is a prognostic factor of gastric cancer with normal p53 function
|
Ando, Koji |
|
2013 |
17 |
2 |
p. 255-262 |
article |
16 |
Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis
|
Domori, Koji |
|
2013 |
17 |
2 |
p. 263-272 |
article |
17 |
Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients
|
Kumagai, Koshi |
|
2013 |
17 |
2 |
p. 273-280 |
article |
18 |
Nishi Memorial Award in Gastric Cancer
|
|
|
2014 |
17 |
2 |
p. 397 |
article |
19 |
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
|
Lordick, Florian |
|
2013 |
17 |
2 |
p. 213-225 |
article |
20 |
Simple pathological examination technique for detection of cancer located at the surgical margin of the stomach
|
Okuda, Kotaro |
|
2013 |
17 |
2 |
p. 281-286 |
article |
21 |
Single-incision laparoscopic total gastrectomy with D1+beta lymph node dissection for proximal early gastric cancer
|
Ahn, Sang-Hoon |
|
2013 |
17 |
2 |
p. 392-396 |
article |
22 |
Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines
|
Kodera, Yasuhiro |
|
2013 |
17 |
2 |
p. 206-212 |
article |
23 |
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
|
Takahari, Daisuke |
|
2013 |
17 |
2 |
p. 383-386 |
article |
24 |
The earlier the better?
|
Terashima, Masanori |
|
2013 |
17 |
2 |
p. 197-199 |
article |
25 |
The safety and feasibility of early postoperative oral nutrition on the first postoperative day after gastrectomy for gastric carcinoma
|
Jeong, Oh |
|
2013 |
17 |
2 |
p. 324-331 |
article |
26 |
Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
|
Fujitani, Kazumasa |
|
2013 |
17 |
2 |
p. 348-353 |
article |
27 |
Time trend of medical economic outcomes of endoscopic submucosal dissection for gastric cancer in Japan: a national database analysis
|
Murata, Atsuhiko |
|
2013 |
17 |
2 |
p. 294-301 |
article |
28 |
Treatment selection for gastric cancer with portal hypertension: clinical management
|
Jin, Zhou-Xiang |
|
2013 |
17 |
2 |
p. 302-309 |
article |
29 |
What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel
|
Dixon, Matthew |
|
2013 |
17 |
2 |
p. 377-382 |
article |